AIML.CN stock opened the market at C$0.04 on 02 Mar 2026 after a -11.11% one-day decline as volume hit 1,183,540.00 shares. The CNQ-listed AI/ML Innovations Inc. (Canada) is trading near its low of C$0.03 for the year while its year high is C$0.12. Investors in AI healthcare names should weigh patent progress and cash runway against weak margins and negative EPS of -0.03 per share.

AIML.CN stock: intraday price action and liquidity

Today AIML.CN stock is at C$0.04, down -11.11% from the previous close of C$0.045 with traded volume 1,183,540.00 compared with average volume 415,292.00. The relative volume spike signals short-term attention in market hours, but price averages show a 50-day mean of C$0.04 and a 200-day mean of C$0.05, underlining low-price volatility and tight intraday ranges.

AIML.CN stock: fundamentals and valuation

AI/ML Innovations Inc. reports negative earnings with EPS -0.03 and a trailing PE of -1.33, reflecting current losses. Key ratios show price-to-sales 40.00 and price-to-book 5.23, which imply the market values growth potential over present revenue. The company holds cash per share 0.01 and a current ratio 2.09, but operating cash flow per share is -0.03, indicating limited internal liquidity.

AIML.CN stock: technicals and trading signals

Technical readings for AIML.CN stock show RSI 70.95, near overbought, and CCI 129.96, suggesting momentum after recent moves. Bollinger Bands sit at 0.03-0.04, reinforcing a narrow trading range. Traders should note OBV 1,250,137.00 and an ADX 13.73, which points to low trend strength despite short-term momentum.

AIML.CN stock: Meyka AI grade and model forecast

Meyka AI rates AIML.CN with a score out of 100: Score 62.30 | Grade B | Suggestion: HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a monthly price of C$0.02 and a yearly price of C$0.01, compared with the current C$0.04, implying a short-term downside. Forecasts are model-based projections and not guarantees.

AIML.CN stock: catalysts, risks and sector context

Primary catalysts for AIML.CN stock are patent approvals and commercial traction for its wearable and digital health systems. Major risks include persistent negative margins, low revenue per share 0.00, and limited analyst coverage; company ratings show a recent third-party score of C- with a strong sell signal on fundamentals. In the Canadian Healthcare sector, AIML.CN stock trades well below large-cap peers, and sector weakness (YTD negative performance) increases sensitivity to news.

AIML.CN stock: price targets and scenario analysis

Realistic price targets for AIML.CN stock: bear C$0.02 (down -50.00%), base C$0.06 (up +50.00%), bull C$0.12 (up +200.00%) using the year high as a bull anchor. These targets account for cash runway, dilution risk, and adoption milestones. Our scenario models use enterprise value multiples and revenue scaling; any positive clinical or commercial news could compress downside and lift the base-case target.

Final Thoughts

Key takeaways on AIML.CN stock: the CNQ-listed AI/ML Innovations Inc. trades at C$0.04 with heavy intraday liquidity of 1,183,540.00 shares and weak earnings metrics (EPS -0.03, PE -1.33). Meyka AI’s models and grade (Score 62.30, Grade B, Suggestion HOLD) flag a cautious stance. Meyka AI’s forecast model projects a monthly price of C$0.02 and a yearly price of C$0.01, implying immediate downside of -50.00% and longer-term downside near -78.92% versus the current price; forecasts are model-based projections and not guarantees. For active AI stocks investors, the trade in AIML.CN stock is catalyst-driven: patent progress or new partnerships could justify the C$0.06 base-case target, while continued losses and dilution would favor the C$0.02 bear case. We note sector context in Canada where healthcare AI names face higher scrutiny on revenue proof points. For more on live metrics and screening, see our AIML.CN stock page and compare recent peer commentary on Investing.com comparisons and Investing.com competitor lists. Meyka AI provides this AI-powered market analysis as informational guidance, not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.